Radio and PodcastRadio and PodcastLive Radio & Podcasts
Updates on capivasertib, belzutifan, talquetamab, & durvalumab artwork
Science & Medicine

Updates on capivasertib, belzutifan, talquetamab, & durvalumab

OncoPharm by OncoPharmPod

Jun 18, 202600:19:32Science & Medicine

Lots of bite-size updates in this episode. Capitello-281: capivasertib + abiraterone (+ prednisone + ADT) Adjuvant Belzutifan + Pemroblizumab is FDA approved Durvalumab approved with BCG for non-muscle invasive bladder c...

About This Episode

Updates on capivasertib, belzutifan, talquetamab, & durvalumab is an episode from OncoPharm by OncoPharmPod. Lots of bite-size updates in this episode. Capitello-281: capivasertib + abiraterone (+ prednisone + ADT) Adjuvant Belzutifan + Pem...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 18, 2026, 00:19:32 long, audio available.

Related Episodes

Continue listening to more episodes from OncoPharm.

Endurance Part 2

Jul 16, 2026 - 00:15:12

Did lenalidomide maintenance in multiple myeloma just get limited to 2 years? Endurance Trial, Part 2: Le...

Asco '26

Jun 11, 2026 - 00:25:38

ASCO 2026 is a wrap, and we needed an extra week to digest it all! Here the review list: 1. RASolute 302...

Pivekimab sunirine

May 28, 2026 - 00:13:49

Pivekimab sunirine, a novel CD-123 antibody drug conjugate is approved for Blastic Plasmacytoid Dendritic...

IMHOTEP, PJP, and more

May 14, 2026 - 00:09:59

This week's pod has lots of updates! IMHOTEP: Pre-operative doses of pembrolizumab lead to significant pC...

Vepdegestrant

May 7, 2026 - 00:11:35

The latest FDA drug approval is vepdegestrant, a heterobifunctional protein degrader, for ESR1 mutated br...